Recruiting NA INTERVENTIONAL 2-arm NCT03517761

Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries

A Single-Blinded, Randomized Controlled Trial Evaluating the Use of Bone Marrow Concentrate for the Treatment of Alar, Accessory, and Transverse Ligament Injuries

Sponsor: Regenexx, LLC

Conditions Craniocervical Injuries

Interventions Bone Marrow Concentrate treatment Sham Control

Updated 10 times since 2018 Last updated: Apr 2, 2025 Started: Mar 23, 2018 Primary completion: Dec 31, 2030 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Craniocervical Injuries and is currently actively recruiting participants. Regenexx, LLC leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

May 2025 — Present [monthly]

Recruiting NA
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA
Feb 2022 — Oct 2023 [monthly]

Recruiting NA

▶ Show 5 earlier versions

Jan 2021 — Feb 2022 [monthly]

Recruiting NA
Sep 2020 — Jan 2021 [monthly]

Recruiting NA
Aug 2019 — Sep 2020 [monthly]

Recruiting NA
Aug 2018 — Aug 2019 [monthly]

Recruiting NA
Jun 2018 — Aug 2018 [monthly]

Recruiting NA

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regenexx, LLC

Data source: Regenexx, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Broomfield, United States